Big pharma co buys $16.6bn for heart tech company

02-11-2022

Staff Writer

Big pharma co buys $16.6bn for heart tech company

Johnson & Johnson (J&J) has agreed to acquire Abiomed, a cardiovascular medical technology company, for $16.6 billion.


Johnson & Johnson, J&J, Abiomed, cardiovascular, medtech, mergers and acquisitions, M&A, US, Americas, big pharma

LSIPR